Winston Pharmaceuticals, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Winston Pharmaceuticals, Inc.
While the unprecedented number of major drugs losing patent protection in 2011 and 2012 has cast a gloomy shadow, the industry has quietly had one of its best years for launching novel therapies.
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions
Perhaps because the ideal analgesic has yet to be discovered, there is intense clinical trial activity in the pain area. Furthermore, there is a good chance that the next few years will witness at least one new class of analgesic reach the market.
We examine ranges of up-front payments in deals over the past year by therapeutic category.
- Specialty Pharmaceuticals
- Other Names / Subsidiaries
- Getting Ready Corporation
- Winston Laboratories